The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has selected eight new member-led technology and workforce development projects totaling $9.7 million in NIIMBL funding and member co-investment through its Project Call 9.1. Featuring 39 participating organizations, the projects target…
FAMAR Group, a leading European pharmaceutical Contract Development and Manufacturing Organization (CDMO), has signed a contract manufacturing agreement with GE HealthCare to fill and finish vials of GE HealthCare's iodine-based contrast media, at its newly acquired site in Homburg, Germany, with commercial supply due…
Neurocrine Biosciences, Inc.announced the completion of its acquisition of Soleno Therapeutics, Inc., strengthening the company's leadership in endocrinology and rare disease. The acquisition adds VYKAT™ XR (diazoxide choline) tablets, the first and only approved medicine for hyperphagia in adults and pediatric patien…
OrganaBio, LLC, a manufacturer of GMP cells and blood products and provider of cell isolation and cryopreservation services, has acquired substantially all of the operating assets of San Diego-based Excellos Inc. to create a bicoastal cell therapy contract development and manufacturing organization. Newly formed Organ…
Bora Pharmaceuticals announced that its Board of Directors has approved the acquisition of the GMP manufacturing operations, including the CDMO business, of MacroGenics, Inc., for total consideration of US$122.5 million, subject to customary working capital adjustments, and a contingent consideration of up to $5 mill…
LOTTE Biologics dannounce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company developing one-of-a-kind PD-1/VEGFR2 dual-paratopic antibodies, reinforcing a growing strategic partnership. Building on the antibody development/manufacturing agreement signed in June last year, this continu…
Singapore Post Limited and Fullerton Healthcare Group Private Limited have announced the signing of a Memorandum of Understanding dto explore the co-development of a robust, integrated healthcare delivery ecosystem. This collaboration seeks to explore possibilities to leverage SingPost's nationwide and community infr…
Biogen has significantly expanded its immunology and rare disease portfolio through the acquisition of Apellis Pharmaceuticals, a move that includes a total transaction value of approximately $5.6 billion. The agreement marks a major strategic shift for Biogen as it integrates Apellis’ advanced complement-immunotherap…
Labcorp , a global leader of innovative and comprehensive laboratory services, announced an expanded collaboration with Epic, the nation's leading electronic health record (EHR) supporting hospitals and health systems. Through the collaboration, Labcorp's full test menu will be available through Aura, Epic's unified p…
Suzhou Ribo Life Science Co., Ltd. announced that the Company has entered into a strategic collaboration agreement with Insilico Medicine. Both parties will leverage their respective core strengths in siRNA drug development and AI-powered drug discovery to conduct in-depth collaboration in target discovery, drug molec…
Page 15 of 43